Pacer BioThreat Strategy ETF
VIRS
VIRS was delisted on the 10th of October, 2024.
5 hedge funds and large institutions have $489K invested in Pacer BioThreat Strategy ETF in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
25% more funds holding
Funds holding: 4 → 5 (+1)
71% less capital invested
Capital invested by funds: $1.71M → $489K (-$1.22M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$3.74K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$30 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.25M |
| 2 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$48.6K |
| 3 |
HI
Harbour Investments
Madison,
Wisconsin
|
-$18K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Cambridge Investment Research Advisors
Fairfield,
Iowa
| $247K | -$48.6K | -1,599 | -17% |
|
|
2
Royal Bank of Canada
Toronto,
Ontario, Canada
| $176K | -$1.25M | -41,281 | -88% |
|
3
Osaic Holdings
Scottsdale,
Arizona
| $62K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $4K | +$3.74K | +123 | New |
|
|
HI
5
Harbour Investments
Madison,
Wisconsin
| – | -$18K | -608 | Closed |
|
|
6
Fidelity Investments
Boston,
Massachusetts
| – | +$30 | +1 | New |
|
VIRS Hedge Fund Activity: Q2 2021 in Review
5 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Pacer BioThreat Strategy ETF (VIRS) for Q2 2021, worth a combined $489K — down 71% from $1.71M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new VIRS positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $3.74K. The largest seller was Royal Bank of Canada, cutting an estimated $1.25M.
- 5 institutional investors held Pacer BioThreat Strategy ETF (VIRS) as of Q2 2021, up from 4 in Q1 2021.
- Funds reported $489K of Pacer BioThreat Strategy ETF stock for Q2 2021, down 71% quarter-over-quarter.
- 2 funds opened new Pacer BioThreat Strategy ETF positions in Q2 2021 and 1 closed out, a net change of +1 holder.
- The largest Pacer BioThreat Strategy ETF buyer in Q2 2021 was UBS Group, an estimated $3.74K added.
- The largest Pacer BioThreat Strategy ETF seller in Q2 2021 was Royal Bank of Canada, an estimated $1.25M sold.
Based on aggregated 13F filings for Q2 2021.